Related Experiment Video
Updated: Jun 18, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Hybrid Ablation of Nonparoxysmal Atrial Fibrillation: The Convergent and Totally Thoracoscopic Approaches
HelenMari Merritt-Genore1, Armin Kiankhooy2
1Methodist Physicians Clinic, Omaha, NE 68022, USA.
Insights
Hybrid Team Ablation Approaches combine electrophysiologist and surgeon expertise for improved nonparoxysmal atrial fibrillation treatment. This collaborative strategy offers better patient outcomes than traditional standalone methods.
Area of Science:
- Cardiovascular Medicine
- Cardiac Electrophysiology
- Minimally Invasive Surgery
Background:
- Nonparoxysmal atrial fibrillation presents significant challenges for electrophysiologists and surgeons.
- Traditional treatments like catheter ablation have yielded suboptimal results.
- On-pump Cox-Maze surgery offers efficacy but is limited by invasiveness.
Purpose of the Study:
- To summarize current Hybrid Team Ablation Approaches for nonparoxysmal atrial fibrillation.
- To highlight the collaborative strategy between electrophysiologists and surgeons.
- To discuss the CONVERGE and Totally Thoracoscopic approaches.
Main Methods:
- Review of the CONVERGE IDE trial findings.
- Summary of Hybrid Team Ablation Approaches.
- Analysis of combined ablation strategies.
Main Results:
- Hybrid Team Ablation Approaches have demonstrated improved patient outcomes.
- Collaboration between electrophysiologists and surgeons is crucial for success.
- This approach addresses limitations of standalone methods.
Conclusions:
- Hybrid Team Ablation offers a promising strategy for managing nonparoxysmal atrial fibrillation.
- The collaborative model enhances treatment efficacy and patient care.
- Further adoption of these combined approaches is recommended.
Abstract:
Nonparoxysmal atrial fibrillation continues to challenge electrophysiologist and surgeons alike. Stand-alone endocardial catheter ablation has resulted in less than satisfying results, and while the on-pump Cox-Maze surgery has excellent results, the invasiveness has limited its adoption amongst both referring providers and surgeons. The CONVERGE IDE trial has shed new light on this once dim problem. EPs and Surgeons are now working together in a Hybrid Team Ablation Approach to provide a combined ablation strategy that has improved patient outcomes and rekindled the collaboration necessary to better patient outcomes. We herein summarize the current Hybrid Team Ablation Approaches (CONVERGE and Totally Thoracoscopic) with nonparoxysmal atrial fibrillation.
